International review of blood donation nucleic acid amplification testing

Autores
Faddy, Helen M.; Osiowy, Carla; Custer, Brian; Busch, Michael; Stramer, Susan L.; Adesina, Opeyemi; van de Laar, Thijs; Tsoi, Wai-Chiu; Styles, Claire; Kiely, Phil; Margaritis, Angelo; Kwon, So-Yong; Qiu, Yan; Deng, Xuelian; Lewin, Antoine; Jørgensen, Signe Winther; Erikstrup, Christian; Juhl, David; Sauleda, Silvia; Camacho Rodriguez, Bernardo Armando; Soto Coral, Lisbeth Jennifer Catherine; Gaviria García, Paula Andrea; Oota, Sineenart; O'Brien, Sheila F.; Wendel, Silvano; Castro, Emma; Navarro Pérez, Laura; Harvala, Heli; Davison, Katy; Reynolds, Claire; Jarvis, Lisa; Grabarczyk, Piotr; Kopacz, Aneta; Łętowska, Magdalena; O'Flaherty, Niamh; Young, Fiona; Williams, Padraig; Burke, Lisa; Chua, Sze Sze; Muylaert, An; Page, Isabel; Jones, Ann; Niederhauser, Christoph; Vermeulen, Marion; Laperche, Syria; Gallian, Pierre; Sawadogo, Salam; Satake, Masahiro; Gharehbaghian, Ahmad; Addas-Carvalho, Marcelo; Blanco, Sebastian; Gallego, Sandra Veronica; Seltsam, Axel; Weber Schehl, Marijke; Al-Riyami, Arwa Z.; Al Maamari, Khuloud; Alawi, Fatma Ba; Pandey, Hem Chandra; Mbanya, Dora; Azevedo França, Rochele; Charlewood, Richard
Año de publicación
2024
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Background and Objectives Nucleic acid amplification testing (NAT), in blood services context, is used for the detection of viral and parasite nucleic acids to reduce transfusion-transmitted infections. This project reviewed NAT for screening blood donations globally. Materials and Methods A survey on NAT usage, developed by the International Society of Blood Transfusion Working Party on Transfusion-transmitted Infectious Diseases (ISBT WP-TTID), was distributed through ISBT WP-TTID members. Data were analysed using descriptive statistics. Results Forty-three responses were received from 32 countries. Increased adoption of blood donation viral screening by NAT was observed over the past decade. NAT-positive donations were detected for all viruses tested in 2019 (proportion of donations positive by NAT were 0.0099% for human immunodeficiency virus [HIV], 0.0063% for hepatitis C virus [HCV], 0.0247% for hepatitis B virus [HBV], 0.0323% for hepatitis E virus [HEV], 0.0014% for West Nile virus [WNV] and 0.00005% for Zika virus [ZIKV]). Globally, over 3100 NAT-positive donations were identified as NAT yield or solely by NAT in 2019 and over 22,000 since the introduction of NAT, with HBV accounting for over half. NAT-positivity rate was higher in first-time donors for all viruses tested except WNV. During 2019, a small number of participants performed NAT for parasites (Trypanosoma cruzi, Babesia spp., Plasmodium spp.). Conclusion This survey captures current use of blood donation NAT globally. There has been increased NAT usage over the last decade. It is clear that NAT contributes to improving blood transfusion safety globally; however, there is a need to overcome economic barriers for regions/countries not performing NAT.
Fil: Faddy, Helen M.. School Of Health, University Of The Sunshine Coast,; Australia
Fil: Osiowy, Carla. Public Health Agency of Canada; Canadá
Fil: Custer, Brian. University of California San Francisco; Estados Unidos. Vitalant Research Institute; Estados Unidos
Fil: Busch, Michael. Vitalant Research Institute; Estados Unidos
Fil: Stramer, Susan L.. American Red Cross; Estados Unidos
Fil: Adesina, Opeyemi. Babcock University; Nigeria
Fil: van de Laar, Thijs. Sanquin Research; Países Bajos
Fil: Tsoi, Wai-Chiu. Hong Kong Red Cross Blood Transfusion Service; Hong Kong
Fil: Styles, Claire. Australian Red Cross Lifeblood; Australia
Fil: Kiely, Phil. Australian Red Cross Lifeblood; Australia
Fil: Margaritis, Angelo. Australian Red Cross Lifeblood; Australia
Fil: Kwon, So-Yong. Korean Red Cross Blood Services; Corea del Sur
Fil: Qiu, Yan. Beijing Red Cross Blood Centre; China
Fil: Deng, Xuelian. Dalian Blood Centre; China
Fil: Lewin, Antoine. Medical Affairs and Innovation, Héma-Québec; Canadá
Fil: Jørgensen, Signe Winther. University Aarhus; Dinamarca
Fil: Erikstrup, Christian. University Aarhus; Dinamarca
Fil: Juhl, David. University Hospital of Schleswig-Holstein. Institute of Transfusion Medicine; Alemania
Fil: Sauleda, Silvia. Banc de Sang i Teixits de Catalunya; España
Fil: Camacho Rodriguez, Bernardo Armando. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; Colombia
Fil: Soto Coral, Lisbeth Jennifer Catherine. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; Colombia
Fil: Gaviria García, Paula Andrea. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; Colombia
Fil: Oota, Sineenart. Thai Red Cross Society; Tailandia
Fil: O'Brien, Sheila F.. Canadian Blood Services; Canadá
Fil: Wendel, Silvano. Hospital Sírio-Libanês Blood Bank; Brasil
Fil: Castro, Emma. Centro de Transfusión de la Comunidad Valenciana; España
Fil: Navarro Pérez, Laura. Centro de Transfusión de la Comunidad Valenciana; España
Fil: Harvala, Heli. NHS Blood and Transplant; Reino Unido
Fil: Davison, Katy. NHSBT/UKHSA Epidemiology Unit; Reino Unido
Fil: Reynolds, Claire. NHSBT/UKHSA Epidemiology Unit; Reino Unido
Fil: Jarvis, Lisa. Scottish National Blood Transfusion Service; Reino Unido
Fil: Grabarczyk, Piotr. Institute of Hematology and Transfusion Medicine; Polonia
Fil: Kopacz, Aneta. Institute of Hematology and Transfusion Medicine; Polonia
Fil: Łętowska, Magdalena. Institute of Hematology and Transfusion Medicine; Polonia
Fil: O'Flaherty, Niamh. Irish Blood Transfusion Service; Reino Unido
Fil: Young, Fiona. Irish Blood Transfusion Service; Reino Unido
Fil: Williams, Padraig. Irish Blood Transfusion Service; Reino Unido
Fil: Burke, Lisa. Irish Blood Transfusion Service; Reino Unido
Fil: Chua, Sze Sze. Health Sciences Authority; Singapur
Fil: Muylaert, An. Red Cross Flanders; Bélgica
Fil: Page, Isabel. Centro de Hemoterapia y Hemodonacion de Castilla y Leon; España
Fil: Jones, Ann. Welsh Blood Service; Reino Unido
Fil: Niederhauser, Christoph. Interregional Blood Transfusion SRC; Suiza
Fil: Vermeulen, Marion. The South African National Blood Service; Sudáfrica
Fil: Laperche, Syria. Etablissement Français du Sang; Francia
Fil: Gallian, Pierre. Etablissement Français du Sang; Francia
Fil: Sawadogo, Salam. National Blood Transfusion Center of Burkina Faso; Burkina Faso
Fil: Satake, Masahiro. Japanese Red Cross Blood Service; Japón
Fil: Gharehbaghian, Ahmad. Shahid Beheshti University of Medical Sciences; Irán
Fil: Addas-Carvalho, Marcelo. Universidade Estadual de Campinas; Brasil
Fil: Blanco, Sebastian. Fundación Banco Central de Sangre; Argentina
Fil: Gallego, Sandra Veronica. Universidad Nacional de Córdoba. Facultad de Medicina. Instituto de Virología Dr. J. M. Vanella; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina
Fil: Seltsam, Axel. Bavarian Red Cross Blood Donation Service; Alemania
Fil: Weber Schehl, Marijke. Bavarian Red Cross Blood Donation Service; Alemania
Fil: Al-Riyami, Arwa Z.. Sultan Qaboos University Hospital; Omán
Fil: Al Maamari, Khuloud. Sultan Qaboos University Hospital; Omán
Fil: Alawi, Fatma Ba. Sultan Qaboos University Hospital; Omán
Fil: Pandey, Hem Chandra. All India Institute of Medical Sciences; India
Fil: Mbanya, Dora. National Blood Transfusion Service; Camerún
Fil: Azevedo França, Rochele. Regional Blood Center of Ribeirão Preto; Brasil
Fil: Charlewood, Richard. New Zealand Blood Service; Nueva Zelanda
Materia
NAT
Blood
Virus
ITT
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/234532

id CONICETDig_8681ff4924de8ab02eb705064f1b737e
oai_identifier_str oai:ri.conicet.gov.ar:11336/234532
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling International review of blood donation nucleic acid amplification testingFaddy, Helen M.Osiowy, CarlaCuster, BrianBusch, MichaelStramer, Susan L.Adesina, Opeyemivan de Laar, ThijsTsoi, Wai-ChiuStyles, ClaireKiely, PhilMargaritis, AngeloKwon, So-YongQiu, YanDeng, XuelianLewin, AntoineJørgensen, Signe WintherErikstrup, ChristianJuhl, DavidSauleda, SilviaCamacho Rodriguez, Bernardo ArmandoSoto Coral, Lisbeth Jennifer CatherineGaviria García, Paula AndreaOota, SineenartO'Brien, Sheila F.Wendel, SilvanoCastro, EmmaNavarro Pérez, LauraHarvala, HeliDavison, KatyReynolds, ClaireJarvis, LisaGrabarczyk, PiotrKopacz, AnetaŁętowska, MagdalenaO'Flaherty, NiamhYoung, FionaWilliams, PadraigBurke, LisaChua, Sze SzeMuylaert, AnPage, IsabelJones, AnnNiederhauser, ChristophVermeulen, MarionLaperche, SyriaGallian, PierreSawadogo, SalamSatake, MasahiroGharehbaghian, AhmadAddas-Carvalho, MarceloBlanco, SebastianGallego, Sandra VeronicaSeltsam, AxelWeber Schehl, MarijkeAl-Riyami, Arwa Z.Al Maamari, KhuloudAlawi, Fatma BaPandey, Hem ChandraMbanya, DoraAzevedo França, RocheleCharlewood, RichardNATBloodVirusITThttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Background and Objectives Nucleic acid amplification testing (NAT), in blood services context, is used for the detection of viral and parasite nucleic acids to reduce transfusion-transmitted infections. This project reviewed NAT for screening blood donations globally. Materials and Methods A survey on NAT usage, developed by the International Society of Blood Transfusion Working Party on Transfusion-transmitted Infectious Diseases (ISBT WP-TTID), was distributed through ISBT WP-TTID members. Data were analysed using descriptive statistics. Results Forty-three responses were received from 32 countries. Increased adoption of blood donation viral screening by NAT was observed over the past decade. NAT-positive donations were detected for all viruses tested in 2019 (proportion of donations positive by NAT were 0.0099% for human immunodeficiency virus [HIV], 0.0063% for hepatitis C virus [HCV], 0.0247% for hepatitis B virus [HBV], 0.0323% for hepatitis E virus [HEV], 0.0014% for West Nile virus [WNV] and 0.00005% for Zika virus [ZIKV]). Globally, over 3100 NAT-positive donations were identified as NAT yield or solely by NAT in 2019 and over 22,000 since the introduction of NAT, with HBV accounting for over half. NAT-positivity rate was higher in first-time donors for all viruses tested except WNV. During 2019, a small number of participants performed NAT for parasites (Trypanosoma cruzi, Babesia spp., Plasmodium spp.). Conclusion This survey captures current use of blood donation NAT globally. There has been increased NAT usage over the last decade. It is clear that NAT contributes to improving blood transfusion safety globally; however, there is a need to overcome economic barriers for regions/countries not performing NAT.Fil: Faddy, Helen M.. School Of Health, University Of The Sunshine Coast,; AustraliaFil: Osiowy, Carla. Public Health Agency of Canada; CanadáFil: Custer, Brian. University of California San Francisco; Estados Unidos. Vitalant Research Institute; Estados UnidosFil: Busch, Michael. Vitalant Research Institute; Estados UnidosFil: Stramer, Susan L.. American Red Cross; Estados UnidosFil: Adesina, Opeyemi. Babcock University; NigeriaFil: van de Laar, Thijs. Sanquin Research; Países BajosFil: Tsoi, Wai-Chiu. Hong Kong Red Cross Blood Transfusion Service; Hong KongFil: Styles, Claire. Australian Red Cross Lifeblood; AustraliaFil: Kiely, Phil. Australian Red Cross Lifeblood; AustraliaFil: Margaritis, Angelo. Australian Red Cross Lifeblood; AustraliaFil: Kwon, So-Yong. Korean Red Cross Blood Services; Corea del SurFil: Qiu, Yan. Beijing Red Cross Blood Centre; ChinaFil: Deng, Xuelian. Dalian Blood Centre; ChinaFil: Lewin, Antoine. Medical Affairs and Innovation, Héma-Québec; CanadáFil: Jørgensen, Signe Winther. University Aarhus; DinamarcaFil: Erikstrup, Christian. University Aarhus; DinamarcaFil: Juhl, David. University Hospital of Schleswig-Holstein. Institute of Transfusion Medicine; AlemaniaFil: Sauleda, Silvia. Banc de Sang i Teixits de Catalunya; EspañaFil: Camacho Rodriguez, Bernardo Armando. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; ColombiaFil: Soto Coral, Lisbeth Jennifer Catherine. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; ColombiaFil: Gaviria García, Paula Andrea. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; ColombiaFil: Oota, Sineenart. Thai Red Cross Society; TailandiaFil: O'Brien, Sheila F.. Canadian Blood Services; CanadáFil: Wendel, Silvano. Hospital Sírio-Libanês Blood Bank; BrasilFil: Castro, Emma. Centro de Transfusión de la Comunidad Valenciana; EspañaFil: Navarro Pérez, Laura. Centro de Transfusión de la Comunidad Valenciana; EspañaFil: Harvala, Heli. NHS Blood and Transplant; Reino UnidoFil: Davison, Katy. NHSBT/UKHSA Epidemiology Unit; Reino UnidoFil: Reynolds, Claire. NHSBT/UKHSA Epidemiology Unit; Reino UnidoFil: Jarvis, Lisa. Scottish National Blood Transfusion Service; Reino UnidoFil: Grabarczyk, Piotr. Institute of Hematology and Transfusion Medicine; PoloniaFil: Kopacz, Aneta. Institute of Hematology and Transfusion Medicine; PoloniaFil: Łętowska, Magdalena. Institute of Hematology and Transfusion Medicine; PoloniaFil: O'Flaherty, Niamh. Irish Blood Transfusion Service; Reino UnidoFil: Young, Fiona. Irish Blood Transfusion Service; Reino UnidoFil: Williams, Padraig. Irish Blood Transfusion Service; Reino UnidoFil: Burke, Lisa. Irish Blood Transfusion Service; Reino UnidoFil: Chua, Sze Sze. Health Sciences Authority; SingapurFil: Muylaert, An. Red Cross Flanders; BélgicaFil: Page, Isabel. Centro de Hemoterapia y Hemodonacion de Castilla y Leon; EspañaFil: Jones, Ann. Welsh Blood Service; Reino UnidoFil: Niederhauser, Christoph. Interregional Blood Transfusion SRC; SuizaFil: Vermeulen, Marion. The South African National Blood Service; SudáfricaFil: Laperche, Syria. Etablissement Français du Sang; FranciaFil: Gallian, Pierre. Etablissement Français du Sang; FranciaFil: Sawadogo, Salam. National Blood Transfusion Center of Burkina Faso; Burkina FasoFil: Satake, Masahiro. Japanese Red Cross Blood Service; JapónFil: Gharehbaghian, Ahmad. Shahid Beheshti University of Medical Sciences; IránFil: Addas-Carvalho, Marcelo. Universidade Estadual de Campinas; BrasilFil: Blanco, Sebastian. Fundación Banco Central de Sangre; ArgentinaFil: Gallego, Sandra Veronica. Universidad Nacional de Córdoba. Facultad de Medicina. Instituto de Virología Dr. J. M. Vanella; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; ArgentinaFil: Seltsam, Axel. Bavarian Red Cross Blood Donation Service; AlemaniaFil: Weber Schehl, Marijke. Bavarian Red Cross Blood Donation Service; AlemaniaFil: Al-Riyami, Arwa Z.. Sultan Qaboos University Hospital; OmánFil: Al Maamari, Khuloud. Sultan Qaboos University Hospital; OmánFil: Alawi, Fatma Ba. Sultan Qaboos University Hospital; OmánFil: Pandey, Hem Chandra. All India Institute of Medical Sciences; IndiaFil: Mbanya, Dora. National Blood Transfusion Service; CamerúnFil: Azevedo França, Rochele. Regional Blood Center of Ribeirão Preto; BrasilFil: Charlewood, Richard. New Zealand Blood Service; Nueva ZelandaJohn Wiley and Sons Inc2024-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/234532Faddy, Helen M.; Osiowy, Carla; Custer, Brian; Busch, Michael; Stramer, Susan L.; et al.; International review of blood donation nucleic acid amplification testing; John Wiley and Sons Inc; Vox Sanguinis; 119; 4; 2-2024; 315-3251423-0410CONICET DigitalCONICETenghttps://ri.conicet.gov.ar/handle/11336/234526info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/10.1111/vox.13592info:eu-repo/semantics/altIdentifier/doi/10.1111/vox.13592info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:49:35Zoai:ri.conicet.gov.ar:11336/234532instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:49:36.1CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv International review of blood donation nucleic acid amplification testing
title International review of blood donation nucleic acid amplification testing
spellingShingle International review of blood donation nucleic acid amplification testing
Faddy, Helen M.
NAT
Blood
Virus
ITT
title_short International review of blood donation nucleic acid amplification testing
title_full International review of blood donation nucleic acid amplification testing
title_fullStr International review of blood donation nucleic acid amplification testing
title_full_unstemmed International review of blood donation nucleic acid amplification testing
title_sort International review of blood donation nucleic acid amplification testing
dc.creator.none.fl_str_mv Faddy, Helen M.
Osiowy, Carla
Custer, Brian
Busch, Michael
Stramer, Susan L.
Adesina, Opeyemi
van de Laar, Thijs
Tsoi, Wai-Chiu
Styles, Claire
Kiely, Phil
Margaritis, Angelo
Kwon, So-Yong
Qiu, Yan
Deng, Xuelian
Lewin, Antoine
Jørgensen, Signe Winther
Erikstrup, Christian
Juhl, David
Sauleda, Silvia
Camacho Rodriguez, Bernardo Armando
Soto Coral, Lisbeth Jennifer Catherine
Gaviria García, Paula Andrea
Oota, Sineenart
O'Brien, Sheila F.
Wendel, Silvano
Castro, Emma
Navarro Pérez, Laura
Harvala, Heli
Davison, Katy
Reynolds, Claire
Jarvis, Lisa
Grabarczyk, Piotr
Kopacz, Aneta
Łętowska, Magdalena
O'Flaherty, Niamh
Young, Fiona
Williams, Padraig
Burke, Lisa
Chua, Sze Sze
Muylaert, An
Page, Isabel
Jones, Ann
Niederhauser, Christoph
Vermeulen, Marion
Laperche, Syria
Gallian, Pierre
Sawadogo, Salam
Satake, Masahiro
Gharehbaghian, Ahmad
Addas-Carvalho, Marcelo
Blanco, Sebastian
Gallego, Sandra Veronica
Seltsam, Axel
Weber Schehl, Marijke
Al-Riyami, Arwa Z.
Al Maamari, Khuloud
Alawi, Fatma Ba
Pandey, Hem Chandra
Mbanya, Dora
Azevedo França, Rochele
Charlewood, Richard
author Faddy, Helen M.
author_facet Faddy, Helen M.
Osiowy, Carla
Custer, Brian
Busch, Michael
Stramer, Susan L.
Adesina, Opeyemi
van de Laar, Thijs
Tsoi, Wai-Chiu
Styles, Claire
Kiely, Phil
Margaritis, Angelo
Kwon, So-Yong
Qiu, Yan
Deng, Xuelian
Lewin, Antoine
Jørgensen, Signe Winther
Erikstrup, Christian
Juhl, David
Sauleda, Silvia
Camacho Rodriguez, Bernardo Armando
Soto Coral, Lisbeth Jennifer Catherine
Gaviria García, Paula Andrea
Oota, Sineenart
O'Brien, Sheila F.
Wendel, Silvano
Castro, Emma
Navarro Pérez, Laura
Harvala, Heli
Davison, Katy
Reynolds, Claire
Jarvis, Lisa
Grabarczyk, Piotr
Kopacz, Aneta
Łętowska, Magdalena
O'Flaherty, Niamh
Young, Fiona
Williams, Padraig
Burke, Lisa
Chua, Sze Sze
Muylaert, An
Page, Isabel
Jones, Ann
Niederhauser, Christoph
Vermeulen, Marion
Laperche, Syria
Gallian, Pierre
Sawadogo, Salam
Satake, Masahiro
Gharehbaghian, Ahmad
Addas-Carvalho, Marcelo
Blanco, Sebastian
Gallego, Sandra Veronica
Seltsam, Axel
Weber Schehl, Marijke
Al-Riyami, Arwa Z.
Al Maamari, Khuloud
Alawi, Fatma Ba
Pandey, Hem Chandra
Mbanya, Dora
Azevedo França, Rochele
Charlewood, Richard
author_role author
author2 Osiowy, Carla
Custer, Brian
Busch, Michael
Stramer, Susan L.
Adesina, Opeyemi
van de Laar, Thijs
Tsoi, Wai-Chiu
Styles, Claire
Kiely, Phil
Margaritis, Angelo
Kwon, So-Yong
Qiu, Yan
Deng, Xuelian
Lewin, Antoine
Jørgensen, Signe Winther
Erikstrup, Christian
Juhl, David
Sauleda, Silvia
Camacho Rodriguez, Bernardo Armando
Soto Coral, Lisbeth Jennifer Catherine
Gaviria García, Paula Andrea
Oota, Sineenart
O'Brien, Sheila F.
Wendel, Silvano
Castro, Emma
Navarro Pérez, Laura
Harvala, Heli
Davison, Katy
Reynolds, Claire
Jarvis, Lisa
Grabarczyk, Piotr
Kopacz, Aneta
Łętowska, Magdalena
O'Flaherty, Niamh
Young, Fiona
Williams, Padraig
Burke, Lisa
Chua, Sze Sze
Muylaert, An
Page, Isabel
Jones, Ann
Niederhauser, Christoph
Vermeulen, Marion
Laperche, Syria
Gallian, Pierre
Sawadogo, Salam
Satake, Masahiro
Gharehbaghian, Ahmad
Addas-Carvalho, Marcelo
Blanco, Sebastian
Gallego, Sandra Veronica
Seltsam, Axel
Weber Schehl, Marijke
Al-Riyami, Arwa Z.
Al Maamari, Khuloud
Alawi, Fatma Ba
Pandey, Hem Chandra
Mbanya, Dora
Azevedo França, Rochele
Charlewood, Richard
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv NAT
Blood
Virus
ITT
topic NAT
Blood
Virus
ITT
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Background and Objectives Nucleic acid amplification testing (NAT), in blood services context, is used for the detection of viral and parasite nucleic acids to reduce transfusion-transmitted infections. This project reviewed NAT for screening blood donations globally. Materials and Methods A survey on NAT usage, developed by the International Society of Blood Transfusion Working Party on Transfusion-transmitted Infectious Diseases (ISBT WP-TTID), was distributed through ISBT WP-TTID members. Data were analysed using descriptive statistics. Results Forty-three responses were received from 32 countries. Increased adoption of blood donation viral screening by NAT was observed over the past decade. NAT-positive donations were detected for all viruses tested in 2019 (proportion of donations positive by NAT were 0.0099% for human immunodeficiency virus [HIV], 0.0063% for hepatitis C virus [HCV], 0.0247% for hepatitis B virus [HBV], 0.0323% for hepatitis E virus [HEV], 0.0014% for West Nile virus [WNV] and 0.00005% for Zika virus [ZIKV]). Globally, over 3100 NAT-positive donations were identified as NAT yield or solely by NAT in 2019 and over 22,000 since the introduction of NAT, with HBV accounting for over half. NAT-positivity rate was higher in first-time donors for all viruses tested except WNV. During 2019, a small number of participants performed NAT for parasites (Trypanosoma cruzi, Babesia spp., Plasmodium spp.). Conclusion This survey captures current use of blood donation NAT globally. There has been increased NAT usage over the last decade. It is clear that NAT contributes to improving blood transfusion safety globally; however, there is a need to overcome economic barriers for regions/countries not performing NAT.
Fil: Faddy, Helen M.. School Of Health, University Of The Sunshine Coast,; Australia
Fil: Osiowy, Carla. Public Health Agency of Canada; Canadá
Fil: Custer, Brian. University of California San Francisco; Estados Unidos. Vitalant Research Institute; Estados Unidos
Fil: Busch, Michael. Vitalant Research Institute; Estados Unidos
Fil: Stramer, Susan L.. American Red Cross; Estados Unidos
Fil: Adesina, Opeyemi. Babcock University; Nigeria
Fil: van de Laar, Thijs. Sanquin Research; Países Bajos
Fil: Tsoi, Wai-Chiu. Hong Kong Red Cross Blood Transfusion Service; Hong Kong
Fil: Styles, Claire. Australian Red Cross Lifeblood; Australia
Fil: Kiely, Phil. Australian Red Cross Lifeblood; Australia
Fil: Margaritis, Angelo. Australian Red Cross Lifeblood; Australia
Fil: Kwon, So-Yong. Korean Red Cross Blood Services; Corea del Sur
Fil: Qiu, Yan. Beijing Red Cross Blood Centre; China
Fil: Deng, Xuelian. Dalian Blood Centre; China
Fil: Lewin, Antoine. Medical Affairs and Innovation, Héma-Québec; Canadá
Fil: Jørgensen, Signe Winther. University Aarhus; Dinamarca
Fil: Erikstrup, Christian. University Aarhus; Dinamarca
Fil: Juhl, David. University Hospital of Schleswig-Holstein. Institute of Transfusion Medicine; Alemania
Fil: Sauleda, Silvia. Banc de Sang i Teixits de Catalunya; España
Fil: Camacho Rodriguez, Bernardo Armando. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; Colombia
Fil: Soto Coral, Lisbeth Jennifer Catherine. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; Colombia
Fil: Gaviria García, Paula Andrea. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; Colombia
Fil: Oota, Sineenart. Thai Red Cross Society; Tailandia
Fil: O'Brien, Sheila F.. Canadian Blood Services; Canadá
Fil: Wendel, Silvano. Hospital Sírio-Libanês Blood Bank; Brasil
Fil: Castro, Emma. Centro de Transfusión de la Comunidad Valenciana; España
Fil: Navarro Pérez, Laura. Centro de Transfusión de la Comunidad Valenciana; España
Fil: Harvala, Heli. NHS Blood and Transplant; Reino Unido
Fil: Davison, Katy. NHSBT/UKHSA Epidemiology Unit; Reino Unido
Fil: Reynolds, Claire. NHSBT/UKHSA Epidemiology Unit; Reino Unido
Fil: Jarvis, Lisa. Scottish National Blood Transfusion Service; Reino Unido
Fil: Grabarczyk, Piotr. Institute of Hematology and Transfusion Medicine; Polonia
Fil: Kopacz, Aneta. Institute of Hematology and Transfusion Medicine; Polonia
Fil: Łętowska, Magdalena. Institute of Hematology and Transfusion Medicine; Polonia
Fil: O'Flaherty, Niamh. Irish Blood Transfusion Service; Reino Unido
Fil: Young, Fiona. Irish Blood Transfusion Service; Reino Unido
Fil: Williams, Padraig. Irish Blood Transfusion Service; Reino Unido
Fil: Burke, Lisa. Irish Blood Transfusion Service; Reino Unido
Fil: Chua, Sze Sze. Health Sciences Authority; Singapur
Fil: Muylaert, An. Red Cross Flanders; Bélgica
Fil: Page, Isabel. Centro de Hemoterapia y Hemodonacion de Castilla y Leon; España
Fil: Jones, Ann. Welsh Blood Service; Reino Unido
Fil: Niederhauser, Christoph. Interregional Blood Transfusion SRC; Suiza
Fil: Vermeulen, Marion. The South African National Blood Service; Sudáfrica
Fil: Laperche, Syria. Etablissement Français du Sang; Francia
Fil: Gallian, Pierre. Etablissement Français du Sang; Francia
Fil: Sawadogo, Salam. National Blood Transfusion Center of Burkina Faso; Burkina Faso
Fil: Satake, Masahiro. Japanese Red Cross Blood Service; Japón
Fil: Gharehbaghian, Ahmad. Shahid Beheshti University of Medical Sciences; Irán
Fil: Addas-Carvalho, Marcelo. Universidade Estadual de Campinas; Brasil
Fil: Blanco, Sebastian. Fundación Banco Central de Sangre; Argentina
Fil: Gallego, Sandra Veronica. Universidad Nacional de Córdoba. Facultad de Medicina. Instituto de Virología Dr. J. M. Vanella; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina
Fil: Seltsam, Axel. Bavarian Red Cross Blood Donation Service; Alemania
Fil: Weber Schehl, Marijke. Bavarian Red Cross Blood Donation Service; Alemania
Fil: Al-Riyami, Arwa Z.. Sultan Qaboos University Hospital; Omán
Fil: Al Maamari, Khuloud. Sultan Qaboos University Hospital; Omán
Fil: Alawi, Fatma Ba. Sultan Qaboos University Hospital; Omán
Fil: Pandey, Hem Chandra. All India Institute of Medical Sciences; India
Fil: Mbanya, Dora. National Blood Transfusion Service; Camerún
Fil: Azevedo França, Rochele. Regional Blood Center of Ribeirão Preto; Brasil
Fil: Charlewood, Richard. New Zealand Blood Service; Nueva Zelanda
description Background and Objectives Nucleic acid amplification testing (NAT), in blood services context, is used for the detection of viral and parasite nucleic acids to reduce transfusion-transmitted infections. This project reviewed NAT for screening blood donations globally. Materials and Methods A survey on NAT usage, developed by the International Society of Blood Transfusion Working Party on Transfusion-transmitted Infectious Diseases (ISBT WP-TTID), was distributed through ISBT WP-TTID members. Data were analysed using descriptive statistics. Results Forty-three responses were received from 32 countries. Increased adoption of blood donation viral screening by NAT was observed over the past decade. NAT-positive donations were detected for all viruses tested in 2019 (proportion of donations positive by NAT were 0.0099% for human immunodeficiency virus [HIV], 0.0063% for hepatitis C virus [HCV], 0.0247% for hepatitis B virus [HBV], 0.0323% for hepatitis E virus [HEV], 0.0014% for West Nile virus [WNV] and 0.00005% for Zika virus [ZIKV]). Globally, over 3100 NAT-positive donations were identified as NAT yield or solely by NAT in 2019 and over 22,000 since the introduction of NAT, with HBV accounting for over half. NAT-positivity rate was higher in first-time donors for all viruses tested except WNV. During 2019, a small number of participants performed NAT for parasites (Trypanosoma cruzi, Babesia spp., Plasmodium spp.). Conclusion This survey captures current use of blood donation NAT globally. There has been increased NAT usage over the last decade. It is clear that NAT contributes to improving blood transfusion safety globally; however, there is a need to overcome economic barriers for regions/countries not performing NAT.
publishDate 2024
dc.date.none.fl_str_mv 2024-02
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/234532
Faddy, Helen M.; Osiowy, Carla; Custer, Brian; Busch, Michael; Stramer, Susan L.; et al.; International review of blood donation nucleic acid amplification testing; John Wiley and Sons Inc; Vox Sanguinis; 119; 4; 2-2024; 315-325
1423-0410
CONICET Digital
CONICET
url http://hdl.handle.net/11336/234532
identifier_str_mv Faddy, Helen M.; Osiowy, Carla; Custer, Brian; Busch, Michael; Stramer, Susan L.; et al.; International review of blood donation nucleic acid amplification testing; John Wiley and Sons Inc; Vox Sanguinis; 119; 4; 2-2024; 315-325
1423-0410
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://ri.conicet.gov.ar/handle/11336/234526
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/10.1111/vox.13592
info:eu-repo/semantics/altIdentifier/doi/10.1111/vox.13592
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv John Wiley and Sons Inc
publisher.none.fl_str_mv John Wiley and Sons Inc
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842268982094069760
score 13.13397